ArriVent BioPharma, Inc. (AVBP) vs OrthoPediatrics Corp. (KIDS)
A side-by-side comparison of ArriVent BioPharma, Inc. and OrthoPediatrics Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVBP
ArriVent BioPharma, Inc.
$15.09HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
KIDS
OrthoPediatrics Corp.
$22.71HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AVBP vs KIDS
growth of $100 · dividends reinvested · last 3yAVBP +42.3% (+12.5%/yr)KIDS -13.2% (-4.6%/yr)AVBP compounded faster over this window
AVBP KIDS
AVBP vs KIDS: by the numbers
- •AVBP is the larger company ($703M vs $583M market cap).
- •Both run net losses; AVBP's is the smaller (0.00% vs -15.72% net margin).
Metrics side by side
Valuation
| Metric | AVBP | KIDS |
|---|---|---|
| P/S ratio | N/A | 2.31 |
| P/B ratio | 1.92 | 1.70 |
Profitability
| Metric | AVBP | KIDS |
|---|---|---|
| Gross margin | 0.00% | 73.65% |
| Operating margin | 0.00% | -9.01% |
| Net margin | 0.00% | -15.72% |
| ROE | -44.63% | -11.56% |
| ROIC | -47.96% | -4.97% |
Growth (annualized)
| Metric | AVBP | KIDS |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 23.14% |
| Total return CAGR (5Y) | N/A | -18.40% |
Go deeper
Dig into the metrics
ArriVent BioPharma ROEOrthoPediatrics ROEArriVent BioPharma operating marginOrthoPediatrics operating marginArriVent BioPharma revenue growthOrthoPediatrics revenue growthArriVent BioPharma free cash flowOrthoPediatrics free cash flow
ArriVent BioPharma & OrthoPediatrics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.